Modern Management of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a multi-part educational video series to support hematologists/oncologists and multidisciplinary care teams in making evidence-based, patient-centered decisions for the management of BPDCN. The series emphasizes early recognition and diagnosis, safe delivery of therapy, proactive management of treatment-related toxicities such as capillary leak syndrome, and coordination of care across academic and community settings.
Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO, Associate Professor of Medicine at Duke University School of Medicine and Chief Patient Experience and Safety Officer at Duke Cancer Institute, and Taylor Kujawa, PharmD, Hematology Clinical Pharmacist at Huntsman Cancer Institute at University of Utah, discuss their own experiences treating BPDCN as well as emerging data shaping the field. Across three videos, gain insights and learn best practices for managing this disease and improving patient outcomes.
Learning Objectives
- Describe the clinical presentation, diagnostic approach, and patient journey in BPDCN.
- Guide safe treatment delivery and toxicity management, focusing on capillary leak syndrome.
- Promote multidisciplinary collaboration and shared care models to optimize outcomes in BPDCN.
Made possible with support from Menarini-Stemline.